ACT-AD is a coalition of committed national organizations seeking to accelerate the development of potential cures and treatments to slow, halt or reverse the progression of Alzheimer’s disease through research.

Find Out More

This is where you can find out the latest in news from the coalition. To join ACT-AD, click here.

Find Out More
  • Activities

    On July 19, the ACT-AD Coalition hosted a one-hour webinar on clinical meaningfulness in Alzheimer’s disease. The webinar highlighted the history of co-primary outcomes for measuring clinical meaningfulness in overt dementia; explored how thinking on co-primary endpoints is evolving as treatment moves earlier in the disease course; and examined if policy recommendations are necessary for future success in the Alzheimer’s disease clinical trial (Go here to watch an archived version.)

  • Take Action

    Today Alzheimer's disease, or AD, is a fatal diagnosis with death preceded by a slow, painful decline and loss of quality of life. The ACT-AD Coalition believes we have the ability to vastly improve the outlook for people with AD and thier caregivers in the next decade and we are committed to working with a diverse group of stakeholders to Accelerate a Cure and Treatments for Alzheimer's Disease. (More Info)

  • Latest News

    Mark your calendars! ACT-AD’s Ninth Annual FDA/AD Allies Meeting is set for Wednesday, November 16, 2016, at the Bethesda North Marriott Hotel and Conference Center (5701 Marinelli Road, North Bethesda, Maryland, 20852). We’ll be posting additional details over the next few months. You can also send an email to Cynthia Bens for more information or sign up for our newsletter list. (More Info)